Core Laboratories

Legacy Oilfield Demand Will Plunge As Renewables Expand

AnalystLowTarget

Not Invested

Community Contributor

Published

15 May 25

AnalystLowTarget's Fair Value

US$10.00

27.9% overvalued

10 Sep

US$12.79

-31.0%

5.4%

-31.0%

5.4%

You can edit this narrative until May 15 10:08 PM. Then, changes will post as Updates.

Author's Valuation

US$1027.9% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$10

27.9% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

0.24%

Energy Services revenue growth rate

0.11%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.14%

Calculation

US$40.22m

Earnings '28

14.45x

PE Ratio '28

US$581.06m

Market Cap '28

US$581.06m

Market Cap '28

46.73m

No. shares '28

US$12.44

Share Price '28

US$12.44 Share Price '28

Discounted to 2025 @ 8.10% p.a.

US$9.84

Fair Value '25